首页> 外文会议>Industrial and Systems Engineering Conference >Adaptive Interventions Treatment Modelling and Regimen Optimization Using Sequential Multiple Assignment Randomized Trials (SMART) and Q-learning
【24h】

Adaptive Interventions Treatment Modelling and Regimen Optimization Using Sequential Multiple Assignment Randomized Trials (SMART) and Q-learning

机译:自适应干预治疗建模和方案优化使用顺序多分配随机试验(SMART)和Q-Learning

获取原文

摘要

Nowadays, pharmacological practices are focused on a single best treatment to treat a disease which sounds impractical as the same treatment may not work the same way for every patient. Thus, there is a need of shift towards more patient-centric rather than disease-centric approach, in which personal characteristics of a patient or biomarkers are used to determine the tailored optimal treatment. The "one size fits all" concept is contradicted by research area of personalized medicine. The Sequential Multiple Assignment Randomized Trial (SMART) is a multi-stage trials to inform the development of dynamic treatment regimens (DTR's). In SMART, a subject is randomized through different stages of treatment where each stage corresponds to a treatment decision. These types of adaptive interventions are individualized and are repeatedly adjusted across time based on patient's individual clinical characteristics and ongoing performance. The reinforcement learning (Q-learning), a computational algorithm for optimization of treatment regimens to maximize desired clinical outcome is used in optimizing the sequence of treatments. This statistical model contains regression analysis for function approximation of data from clinical trials. The model will predict a series of regimens across time, depending on the biomarkers of a new participant for optimizing the weight management decision rules.
机译:如今,药理实践的重点是单一的最佳治疗方法,以治疗疾病,因为相同的治疗可能无法对每个患者的方式相同的方式工作。因此,需要转向更患者以更高的患者为中心的,而不是以象征为中心的方法,其中患者或生物标志物的个人特征用于确定量身定制的最佳处理。 “一种尺寸适合所有”概念由个性化医学的研究领域相矛盾。顺序多分配随机试验(SMART)是一种多级试验,以提供动态治疗方案的发展(DTR's)。在智能中,通过不同的治疗阶段随机化,每个阶段对应于治疗决策。这些类型的自适应干预是个性化的,基于患者的个体临床特征和持续的性能,在时间跨时间重复调整。用于优化治疗方案的计算算法,以最大化所需的临床结果的计算算法用于优化治疗序列。该统计模型包含来自临床试验的数据近似的回归分析。根据新参与者的生物标志物,该模型将预测一系列一系列方案,以优化重量管理决策规则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号